Skip to Main Content
Try STAT+ TODAY
Trending:
Biotech
Pharmalot
Coronavirus
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Politics
STAT+

Democrats have their best shot yet at letting Medicare negotiate drug prices — but it’s still not a done deal

  • Nicholas Florko
  • Lev Facher

By Nicholas Florko and Lev Facher Jan. 11, 2021

Reprints
Democrat Drug Price Rebuttal
Sen. Chuck Schumer (D-N.Y.) will be the majority leader. AP Photo/Alex Brandon

WASHINGTON — Democrats have their best shot in more than a decade to deliver on one of the party’s central health care promises: allowing Medicare to directly negotiate prescription drug prices.

But it’s far from guaranteed that they can deliver.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Authors Reprints

Nicholas Florko

Nicholas Florko

Reporter, Commercial Determinants of Health

Nicholas Florko reports on the commercial determinants of health.

Lev Facher

Lev Facher

Addiction Reporter

Lev covers the U.S. addiction and overdose crisis.

Tags

Who will get the call from Stockholm? It’s time…
Who will get the call from Stockholm? It’s time for STAT’s 2022 Nobel Prize predictions
Push to double up on Covid booster and flu…
Push to double up on Covid booster and flu shot may have a downside, experts caution
‘Microdosing’ is touted by ’shroomers and Reddit users. Science…
‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims —…
CAR-T therapy doesn’t work in all cancer cases. Scientists…
CAR-T therapy doesn’t work in all cancer cases. Scientists are starting to figure out why
At Verily, a growing line of business builds on…
At Verily, a growing line of business builds on a revolving door to the FDA
Get a Ph.D. in health policy — from a…
Get a Ph.D. in health policy — from a single Powerpoint slide

Recommended Stories